Bio-Rad Laboratories Inc. (BIO) Tops Q4 EPS Views; Revs Light
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $386.12 --0%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $2.08, $0.41 better than the analyst estimate of $1.67. Revenue for the quarter came in at $550.2 million versus the consensus estimate of $562.06 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Citi raises Atlassian price target to $225, maintains Buy rating
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
